Who We Are

Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. Our treatment centers provide medication-assisted treatment in an outpatient setting. With 55 locations across 13 states, BHG provides services to thousands of individuals and their communities across the country.

Mission & Values

BHG’s mission is to be the best-in-class network of opioid treatment facilities by producing superior patient outcomes. We accomplish this goal by providing each person who enters our programs with a medically based treatment experience in accordance with our governing bodies. Our treatment programs rehabilitate those aspects of the person which are suffering; builds upon the strengths of that person; protects that person’s rights to privacy, respect and dignity; and assists in the development of a better quality of life. In doing so, we improve the lives and communities of those we touch and serve, and we build a strong company that serves its patients and communities over the long term.

Our core values are:

  • Character: honesty, fairness and integrity
  • Enthusiasm: vigorous commitment to everything we do
  • Compassion: unwavering, disciplined support for the patient
  • Teamwork: shared leadership and rewards
  • Perseverance: diligence and hard work

Behavioral Health Group Treatment Centers are accredited by the Joint Commission on Accreditation of Healthcare Organizations.

Meet Our Leadership Team

View

Jay Higham
Chief Executive Officer

Jay Higham is an experienced health care services executive with over 30 years of experience driving organizational success in high growth, multi-location, emerging health care businesses. He has been recognized for consistently leading business expansion through infrastructure development, new or repositioned products and services, pricing and financing models, market expansion, acquisitions and new location development. He is adept at sourcing public and private capital, and the investor and community relations required for expanded market penetration.

Jay is passionate about BHG’s mission to help solve the growing opioid addiction epidemic in the United States. In joining BHG, his vision was to help expand access to medication-assisted treatment, the gold standard of care. In support of these efforts, he directed and oversaw the development of the Revenue Cycle Management Department, increasing BHG’s ability to partner with 3rd party providers. Jay has also been committed to improving BHG facilities and technology across the company. As CEO, he has led the company in a dedication to providing high-quality care under the disease model of addiction.

Prior to joining BHG, Jay was Chairman, President and CEO of IntegraMed Amercia, Inc., a Nasdaq listed company which was the leading provider of infertility and varicose vein treatment in the United States. During a 10-year period, he led the company’s growth from four locations in New York to a national network of over 175 locations.

Christopher Marshall, M.D.
National Medical Director

Dr. Marshall received a Bachelor of Science in Biology and a Bachelor of Arts in Philosophy from The University of Tennessee at Martin. He received his Doctorate of Medicine from the University of Tennessee College of Medicine and completed a Family Medicine Residency through the University of Louisville in Glasgow, Kentucky, where he first became interested in addiction medicine. He became board certified in Family Medicine in 2009 and then in Addiction Medicine in 2010 through the American Society of Addiction Medicine. For five years, Dr. Marshall practiced Family and Addiction Medicine before transitioning to full time addiction treatment with Behavioral Health Group in 2014.

As the National Medical Director for BHG, Dr. Marshall provides leadership and guidance in support of the medical mission of BHG. That mission is to provide medication-assisted treatment with a sense of hope and respect. Dr. Marshall currently provides care for BHG patients in West Tennessee.

Before becoming National Medical Director, Dr. Marshall worked for BHG at treatment centers in Jackson, Paris and Dyersburg, TN, as well as Paducah, KY. Dr. Marshall also holds a teaching position on faculty with the Addiction Medicine Fellowship program through the University of Tennessee. Most recently, he received the new board certification in Addiction Medicine through the American Board of Preventive Medicine.

Dwight Mussleman
Chief Development Officer

Dwight brings 26 years of healthcare corporate and business development expertise to Behavioral Health Group. As Chief Development Officer, Dwight is responsible for establishing and fostering key external relationships to successfully enter new markets and expand the company’s presence nationwide via treatment center acquisition, de novo (new site) development and real estate. In addition to overseeing acquisitions, he has provided leadership for BHG’s many infrastructure improvement projects.

Before joining BHG, Dwight served as Vice President of Business Development with Alliance Oncology where he led the oncology division’s strategy of acquiring community cancer centers and partnering with hospital based cancer centers. Prior to his position with Alliance, Dwight led all the business development activities including sales strategy, mergers and acquisitions and product offering as Vice President of Business Development for Global Physics Solutions. Prior to Global Physics, Dwight spent 14+ years with US Oncology in various roles including Vice President of Physician Development where he established the internal physician recruiting department and lead in market acquisitions.

Jeremy Wilkerson
President of OTP Services

Jeremy brings 16 years of healthcare operations and general management experience serving in diverse healthcare industries that include dialysis, prisons, home health and clinical trials. He has a consistent track record for success managing hyper-growth and turn-arounds in multi-site healthcare industries. In his role at BHG, Jeremy leads efforts in existing clinics to optimize clinical and business outcomes. Jeremy has been instrumental in developing and driving key performance metrics throughout the organization and promoting a culture within the company based on the brain disease model of addiction treatment.

Prior to joining Behavioral Health Group, Jeremy was the President of a clinical research organization that provided full outsourcing solutions for clinical trials for complex biologic drugs at sites across 12 states.

Marlin Martin, MSW, LCSW, C-ASWCM
Senior Vice President- Regulatory and Clinical Affairs

Marlin brings 36 years of combined medical and mental health leadership expertise to BHG. As VP of Regulatory and Clinical Affairs, Marlin is responsible for providing the leadership, management, and vision necessary to ensure that the organization has the proper administrative and regulatory reporting procedures and systems in place to effectively grow the organization and to ensure financial strength and regulatory compliance. In addition, Marlin serves as the Program Sponsor for each BHG program and he chairs the Compliance and Regulatory Affairs subcommittee sponsored by BHG’s Board of Directors.

Before joining BHG, Marlin held leadership positions at the Missouri Department of Health and Senior Services in the bureau of HIV and Hepatitis, overseeing statewide and regional case management service delivery. In addition he has served as adjunct faculty at several graduate schools of Social Work teaching Policy, Human Diversity and Clinical Interviewing Skills. He has served on numerous non-profit boards, and has engaged in his own private counseling practice.